Incidence rates of kidney and renal pelvis cancers increased in the United States, with notable disparities among racial and ethnic groups from 2000 to 2020.
Researchers from the University of Texas Health Science Center at Houston analyzed data from the Surveillance, Epidemiology, and End Results (SEER) program. They found that the age-standardized incidence rates (ASIRs) per 100,000 for kidney and pelvis cancers were 22.03 for men and 11.14 for women.
Non-Hispanic Black men had the highest ASIR at 24.53 and the greatest increase over the study period, with an average annual percent change (AAPC) of 2.19%. Hispanic men and women also experienced significant increases in ASIRs, with AAPCs of 2.07% and 2.20%, respectively.
The majority of cases occurred among Non-Hispanic Whites (69.75%) and those aged 55-69 years (39.96%)[1]. However, the study highlights the disproportionate burden of kidney cancer among minority populations.
Incidence rates of kidney and renal pelvis cancers increased in the United States, with notable disparities among racial and ethnic groups from 2000 to 2020.
Researchers from the University of Texas Health Science Center at Houston analyzed data from the Surveillance, Epidemiology, and End Results (SEER) program. They found that the age-standardized incidence rates (ASIRs) per 100,000 for kidney and pelvis cancers were 22.03 for men and 11.14 for women.
Non-Hispanic Black men had the highest ASIR at 24.53 and the greatest increase over the study period, with an average annual percent change (AAPC) of 2.19%. Hispanic men and women also experienced significant increases in ASIRs, with AAPCs of 2.07% and 2.20%, respectively.
The majority of cases occurred among Non-Hispanic Whites (69.75%) and those aged 55-69 years (39.96%)[1]. However, the study highlights the disproportionate burden of kidney cancer among minority populations.
“Our findings underscore the need for targeted interventions and further research to address these persistent disparities,” said lead author Dr. Ankit Agarwal from the University of Texas Health Science Center at Houston.
The study leveraged high-quality, population-based data from the SEER program to provide a comprehensive examination of kidney cancer trends in the U.S. However, the authors acknowledge limitations, such as the lack of data on risk factors and potential underreporting of cases.
See “A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000–2020” (May 17, 2024)
